Heartflow, Inc.
HTFLHealthcareNASDAQHealth Information Services · Last scanned Sep 8, 2026
Scan Results
Daily timeframeOperating under the Health Information Services umbrella, Heartflow, Inc. is a healthcare company. HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Valued at $4.25B, HTFL is a mid-cap name in its sector. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
Market Cap
$4.25B
Beta
—
P/E (TTM)
—
P/E (Fwd)
-185.08
EPS (TTM)
$-3.15
EPS (Fwd)
$-0.26
ROE
-154.2%
ROA
-18.1%
Cash
$162.6M
Total Debt
$27.1M
Free CF
-$33.6M
52W Change
40.9%
Annual Financials
Cash vs Debt
Where HTFL stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, HTFL finished 69.38% above its 150-day moving average ($29.52) and 68.29% above its 200-day moving average ($29.71). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HTFL overbought or oversold?
At the September 3, 2026 close, HTFL's RSI(14) was 88.0, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Heartflow, Inc. holds $162.6M in cash against $27.1M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow is running at -$33.6M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -154.2%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $87.2M (2023) to $176.0M (2025), reflecting a 102% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Heartflow, Inc. and its sector.